Sustained long-term improvement of arterial endothelial function in heterozygous familial hypercholesterolemia patients treated with simvastatin
- 31 August 2001
- journal article
- Published by Elsevier BV in Atherosclerosis
- Vol. 157 (2), 423-429
- https://doi.org/10.1016/s0021-9150(00)00733-4
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical managementAtherosclerosis, 1999
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsThe New England Journal of Medicine, 1998
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJama-Journal Of The American Medical Association, 1998
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsThe New England Journal of Medicine, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaThe New England Journal of Medicine, 1995
- The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients.Circulation, 1993
- Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions.JCI Insight, 1993
- Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosisThe Lancet, 1992
- Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease.Circulation, 1990
- Development of coronary heart disease in familial hypercholesterolemia.Circulation, 1989